Nitazoxanide (NSC 697855)

For research use only.

Catalog No.S1627 Synonyms: NTZ

5 publications

Nitazoxanide (NSC 697855) Chemical Structure

CAS No. 55981-09-4

Nitazoxanide (NTZ, NSC 697855) is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent(IC50 for canine influenza virus ranges from 0.17 to 0.21 μM). Nitazoxanide modulates autophagy and inhibits mTORC1 signaling.

Selleck's Nitazoxanide (NSC 697855) has been cited by 5 publications

Purity & Quality Control

Choose Selective Influenza Virus Inhibitors

Biological Activity

Description Nitazoxanide (NTZ, NSC 697855) is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent(IC50 for canine influenza virus ranges from 0.17 to 0.21 μM). Nitazoxanide modulates autophagy and inhibits mTORC1 signaling.
Targets
PFOR [2]
()
mTORC1 [6]
()
In vitro

Nitazoxanide reduces parasite growth in cell culture by more than 90% with little evidence of drug-associated cytotoxicity. [1] Nitazoxanide is a new thiazolide antiparasitic agent that shows excellent in vitro activity against a wide variety of protozoa and helminths. [2] Nitazoxanide and its metabolite tizoxanide are more active in vitro than metronidazole against G. intestinalis, E. histolytica and T. vaginalis. [3] Nitazoxanide exhibits potent inhibition of both HBV and HCV replication. Nitazoxanide potentiates the effect of subsequent treatment with Nitazoxanide plus IFN, but not Nitazoxanide plus 2'CmeC, in HCV replicon-containing cells. Nitazoxanide induces reductions in several HBV proteins (HBsAg, HBeAg, HBcAg) produced by 2.2.15 cells, but does not affect HBV RNA transcription. [4] Nitazoxanide exhibits IC50, and IC90 values of 0.017 and 0.776 mg/mL respectively, against E. histolytica, 0.004 and 0.067 mg/mL against G. intestinalis, and 0.034 and 2.046 mg/mL against T. vaginalis. Nitazoxanide is more toxic than metronidazole and albendazole against E. histolytica. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HepG2(2.2.15) M4T1TmFvfGm4aYLhcEBie3OjeR?= MoHLRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgTIVx[XSrdHnzJGIhfmm{dYOgbY5n\WO2ZXSgbY4hcHWvYX6gTIVxTzJqMj6yMlE2MSClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDlfJRz[WOnbHz1cIFzKH[rcnHsJGRPSSCvZXHzeZJm\CB{NDDodpMh[W[2ZYKgcIF{fCCmb4PlMEBGSzVyPUCuNVLPxE1? M3vXT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNUWzPFEzLz5{MUW1N|gyOjxxYU6=
HepG2(2.2.15) NGjKb5dCdnSrdnnyZYwh[XO|YYm= MknDRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgTGJXKGmwZnXjeIVlKGmwIHj1cYFvKEincFeyLFIvOi5zNTmgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCneITyZYNmdGy3bHHyJJZqemGuIFTORUBt\X[nbDygTWM2OD1yLkGy{txO NEi1dWo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEO4N|I4PCd-MkizPFMzPzR:L3G+
Ava5 M1f1TmFvfGm4aYLhcEBie3OjeR?= NHPvPXc{KGSjeYO= MVHBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDIR3Yh\2Wwb4T5dIUhOWJiaX7m[YN1\WRiaX6gRZZiPSClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJZqemGuIILldIxq[2G2aX;uJIFnfGW{IEOg[IF6eyCkeTDicI91KGi7YoLp[Il7[XSrb36gZY5idHm|aYOsJGVEPTB;MD6yNe69VQ>? M2HDNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEW5PVg{Lz5{MkC1PVk5OzxxYU6=
Huh7.5 M2WxW2FvfGm4aYLhcEBie3OjeR?= MX6zJIRigXN? MX3BcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDIR3Yh\2Wwb4T5dIUhOWFiaX7m[YN1\WRiaX6gTJVpPy53IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yhfmm{YXygdoVxdGmlYYTpc44h[W[2ZYKgN{Bl[Xm|IHL5JIJtd3RiaInidollcXqjdHnvckBidmGueYPpd{whTUN3ME2wMlM{|ryP MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB3OUm4N{c,OjJyNUm5PFM9N2F-
HepG2(2.2.15) MnjnRY51cX[rcnHsJIF{e2G7 NFrLdpdCdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBJ\XCjdHn0bZMhSiC4aYL1d{Bqdm[nY4Tl[EBqdiCqdX3hckBJ\XCJMjiyMlIvOTVrIHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJIlvfHKjY3XscJVt[XJidnnyZYwhTE6DIH3lZZN2emWmIEK0JIhzeyCjZoTldkBt[XO2IHTvd4UtKEWFNUC9NE42Qc7:TR?= NUDhWW53RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG1OVM5OTJpPkKxOVU{QDF{PD;hQi=>
HepG2(2.2.15) M1S3emFvfGm4aYLhcEBie3OjeR?= MojRRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgTIVx[XSrdHnzJGIhfmm{dYOgbY5n\WO2ZXSgbY4hcHWvYX6gTIVxTzJqMj6yMlE2MSClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDlfJRz[WOnbHz1cIFzKH[rcnHsJGRPSSCvZXHzeZJm\CB{NDDodpMh[W[2ZYKgcIF{fCCmb4PlMEBGSzlyPUCuPFPPxE1? M{jrOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNUWzPFEzLz5{MUW1N|gyOjxxYU6=
Ava5 NF7pZXFCdnSrdnnyZYwh[XO|YYm= M2H4O|Mh\GG7cx?= NGPBfoJCdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBJS1ZiZ3Xuc5R6eGViMXKgbY5n\WO2ZXSgbY4hSX[jNTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKH[rcnHsJJJmeGyrY3H0bY9vKGGodHXyJFMh\GG7czDifUBjdG:2IHj5ZpJq\Gm8YYTpc44h[W6jbInzbZMtKEWFOUC9NE46O87:TR?= NW[3dWhXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwOVk6QDNpPkKyNFU6QTh|PD;hQi=>
Huh7.5 NFKzflJCdnSrdnnyZYwh[XO|YYm= NEG3cXc{KGSjeYO= MoXYRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgTGNXKGenbn;0fZBmKDGjIHnu[oVkfGWmIHnuJGh2cDdwNTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKH[rcnHsJJJmeGyrY3H0bY9vKGGodHXyJFMh\GG7czDifUBjdG:2IHj5ZpJq\Gm8YYTpc44h[W6jbInzbZMtKEWFOUC9NU4y|ryP MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB3OUm4N{c,OjJyNUm5PFM9N2F-
BHK-21 MX7BcpRqfmm{YXygZZN{[Xl? M4XX[WFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JGNpcWu3bnf1cpliKH[rcoXzJFA3OTGjVIegbY5n\WO2ZXSgbY4hSkiNLUKxJINmdGy|IHL5JHJVNXGSQ2KgZY5idHm|aYOsJGVEPTB;MT65Ou69VQ>? MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDZ6OUm3OUc,Ojh4OEm5O|U9N2F-
HepG2(2.2.15) NF3IXZpCdnSrdnnyZYwh[XO|YYm= M{fVWGFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JGhmeGG2aYTpd{BDKH[rcoXzJIlv\mWldHXkJIlvKGi3bXHuJGhmeEd{KEKuNk4yPSliY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gbY51emGlZXzseYxieiC4aYLhcEBFVkFibXXhd5Vz\WRiMkSgbJJ{KGGodHXyJIxie3RiZH;z[UwhTUN7ME2yMlHPxE1? MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTV3M{ixNkc,OjF3NUO4NVI9N2F-
HCT8 NIDIPHpCdnSrcHHyZZNqfGmlIHHzd4F6 M{jmWlQ5KGi{cx?= NGrkZ3lCdnSrcHHyZZNqfGmlIHHjeIl3cXS7IHHnZYlve3RiQ4L5dJRwe3CxcnnkbZVuKHCjco\1cUBUWExiaX7m[YN1\WRiaX6gbJVu[W5iSFPUPEBk\WyuczDpcoN2[mG2ZXSg[o9zKDR6IHjyd{BjgSCISWTDM2RCWElic4ThbY5qdmdiYnHz[YQh\my3b4Lld4NmdmOnIHHzd4F6NCCHQ{WwQVIvO87:TR?= MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR4OUW3OUc,Ojl2Nkm1O|U9N2F-
Vero E6 M1XvW2Z2dmO2aX;uJIF{e2G7 MU[0PEBpenN? MXrJR|UxKG[xcjDhcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDTRXJUNUOxVj2yJIlvKHSqZTDW[ZJwKEV4IHPlcIwhdGmwZTDheEA1QCCqIHL5JIludXWwb3\seY9z\XOlZX7j[U1j[XOnZDDhd5NigSBqZHX0[YN1cW6pIITo[UB3cXKjbDDOVEBxem:2ZXnuJIlvKHSqZTDueYNt\XW|IH;mJJRp\SCYZYLvJGU3KGOnbHzzLUwhUUN3ME2yMlgyQDN6zszN NEPmSJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MkO1N|g2QSd-M{KzOVM5PTl:L3G+
HCT8 M{fQPWFvfGmyYYLhd4l1cWNiYYPzZZk> MnXnOFghcHK| MmDqRY51cXCjcnHzbZRq[yCjY4Tpeol1gSCjZ3HpcpN1KEO{eYD0c5Nxd3KrZHn1cUBx[XK4dX2gRmdHKGmwZnXjeIVlKGmwIHj1cYFvKEiFVEigZ4VtdHNiaX7jeYJifGWmIH\vdkA1QCCqcoOgZpkhTkmWQz;ERXBKKHO2YXnubY5oKGKjc3XkJIZtfW:{ZYPj[Y5k\SCjc4PhfUwhTUN3ME2yMlnPxE1? M2DWcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NE[5OVc2Lz5{OUS2PVU4PTxxYU6=
BHK-21 MoLkRY51cX[rcnHsJIF{e2G7 NHrhZWZCdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBEcGmtdX7neY56[SC4aYL1d{Bqdm[nY4Tl[EBqdiCESFutNlEh[2WubIOgZpkhWlRvcWDDVkBidmGueYPpd{whTUN3ME2yMlk3|ryP M{SyV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6Nki5PVc2Lz5{OE[4PVk4PTxxYU6=
U2OS MmDtRY51cX[rcnHsJIF{e2G7 MX;BcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDDbIlsfW6pdX75ZUB3cXK3czDpcoZm[3SnZDDpckBpfW2jbjDVNm9UKGOnbHzzJIJ6KFKWLYHQR3Ih[W6jbInzbZMtKEWFNUC9N{4xOc7:TR?= NV;K[GxbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki2PFk6PzVpPkK4Olg6QTd3PD;hQi=>
HCT8 MmfIRY51cXCjcnHzbZRq[yCjc4PhfS=> NYrzdnJrSW62aYDhdoF{cXSrYzDhZ5Rqfmm2eTDh[4FqdnO2IFPyfZB1d3Oyb4Lp[Il2dSCyYYL2eY0hcW5iSFPUPEBk\WyuczygTWM2OD1|LkK1{txO NX3BRoR6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[0PFAzQDFpPkG2OFgxOjhzPD;hQi=>
HCT-8 M3HZeGFvfGmvaXPyc4Jq[WxiYYPzZZk> M1TNTmFvfGmvaXPyc4Jq[WxiYXP0bZZqfHliYXfhbY5{fCCFconweI9{eG:{aXTpeY0heGG{doXtJIlv\mWldHXkJIlvKGi3bXHuJGhEXC16IHPlcIx{NCCLQ{WwQVMvQM7:TR?= M3\MUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUmxNlgxLz5zOEW5NVI5ODxxYU6=
BHK-21 M2LrU2FvfGm4aYLhcEBie3OjeR?= NUHISJNNSW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhS2ira4Xu[5VvgWFidnnyeZMhODhzMHLUe{Bqdm[nY4Tl[EBqdiCESFutNlEh[2WubIOgZpkhWlRvcWDDVkBidmGueYPpd{whTUN3ME20Mlk2|ryP NFPOSWs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[4PVk4PSd-Mki2PFk6PzV:L3G+
Vero MYPDfZRwfG:6aXPpeJkh[XO|YYm= M3PIT|Q5KGi{cx?= M{nKO2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGGocnnjZY4h\3KnZX6gcY9vc2W7IG\ldo8h[2WubIOgZZN{\XO|ZXSgZZMh[2WubDD2bYFjcWyrdImgZYZ1\XJiNEigbJJ{KGK7IGfTWE0yKGG|c3H5MEBKSzVyPUGwMlc1|ryP M3zDeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|N{i3Nlg6Lz5{M{e4O|I5QTxxYU6=
BHK21 M4m1RWN6fG:2b4jpZ4l1gSCjc4PhfS=> NHnn[5UyPiCqcoO= NILxeo1EgXSxdH;4bYNqfHliYXfhbY5{fCCESFuyNUBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iY3XscEB3cWGkaXzpeJkh[W[2ZYKgNVYhcHK|IHL5JGNEUy16IHHzd4F6NCCFQ{WwQVI2|ryP M4T3b|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6Nki5PVc2Lz5{OE[4PVk4PTxxYU6=
U2OS MoTGR5l1d3SxeHnjbZR6KGG|c3H5 NHO1fZcyPiCqcoO= MUDDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDVNm9UKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkAyPiCqcoOgZpkhS0ONLUigZZN{[XluIFPDOVA:OjYQvF2= Mo\6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh4OEm5O|UoRjJ6Nki5PVc2RC:jPh?=
Ava5 M4frXGN6fG:2b4jpZ4l1gSCjc4PhfS=> MnXSN{Bl[Xm| MkTBR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRZZiPSClZXzsd{Bi\nSncjCzJIRigXNiYomgcoV2fHKjbDDy[YQh\HmnIHHzd4F6NCCFQ{WwQVM2|ryP NHnRWJQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkC1PVk5Oyd-MkKwOVk6QDN:L3G+
Huh7.5 MYDDfZRwfG:6aXPpeJkh[XO|YYm= M2W2eFMh\GG7cx?= NVm2OoJGS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUHWqNz61JINmdGy|IHHmeIVzKDNiZHH5d{BjgSCwZYX0doFtKHKnZDDkfYUh[XO|YYmsJGNEPTB;NEpOwG0> NYnDOYlkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwOVk6QDNpPkKyNFU6QTh|PD;hQi=>
DAOY NIHQeZNyUFSVIHHzd4F6 MX\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhTEGRWTDj[Yxtew>? MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SJ-GBM2 NGfh[oFyUFSVIHHzd4F6 NImwNXVyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1qtS2JOOiClZXzsdy=> NGjwcVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
A673 NH3MXIlyUFSVIHHzd4F6 M{TEXpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCDNkezJINmdGy| MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 NIXtUnpyUFSVIHHzd4F6 MV3xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvM{egZ4VtdHN? MmG1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB-EBc1 Mn76dWhVWyCjc4PhfS=> MlvpdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6ELVXCZ|Eh[2WubIO= NEjHNXo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Saos-2 NVOxU4txeUiWUzDhd5NigQ>? MXzxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW2Gxcz2yJINmdGy| MnPCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB1643 NHvtNVZyUFSVIHHzd4F6 NFnWfXByUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKxOlQ{KGOnbHzz MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
LAN-5 MWDxTHRUKGG|c3H5 NH23[2lyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTFHOMVUh[2WubIO= M33FRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-12 M2DJS5FJXFNiYYPzZZk> MXPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvMUKgZ4VtdHN? M2P6SFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh18 NV3qUZljeUiWUzDhd5NigQ>? MnTQdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKqMUigZ4VtdHN? M1L1OVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
OHS-50 NV7POJZzeUiWUzDhd5NigQ>? MYjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy| NVLFeYlZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
RD MnXidWhVWyCjc4PhfS=> MWDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWkRiY3XscJM> MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-

... Click to View More Cell Line Experimental Data

In vivo

Nitazoxanide is partially effective at reducing the parasite burden in a gnotobiotic piglet diarrhea model when given orally for 11 days at 250 mg/kg/day but not at 125 mg/kg/day. Nitazoxanide induces a drug-related diarrhea in piglets that might have influenced its therapeutic efficacy. [1]

Protocol

Solubility (25°C)

In vitro DMSO 62 mg/mL (201.77 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 307.28
Formula

C12H9N3O5S

CAS No. 55981-09-4
Storage powder
in solvent
Synonyms NTZ
Smiles CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01529073 Unknown status Drug: Nitazoxanide HCV Coinfection|HIV Infection Juan Macías|Spanish National Health System|Andaluz Health Service February 2012 Phase 2
NCT01197157 Completed Drug: Placebo|Drug: Nitazoxanide Hepatitis C National Liver Institute Egypt September 2010 Phase 2|Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Nitazoxanide (NSC 697855) | Nitazoxanide (NSC 697855) ic50 | Nitazoxanide (NSC 697855) price | Nitazoxanide (NSC 697855) cost | Nitazoxanide (NSC 697855) solubility dmso | Nitazoxanide (NSC 697855) purchase | Nitazoxanide (NSC 697855) manufacturer | Nitazoxanide (NSC 697855) research buy | Nitazoxanide (NSC 697855) order | Nitazoxanide (NSC 697855) mouse | Nitazoxanide (NSC 697855) chemical structure | Nitazoxanide (NSC 697855) mw | Nitazoxanide (NSC 697855) molecular weight | Nitazoxanide (NSC 697855) datasheet | Nitazoxanide (NSC 697855) supplier | Nitazoxanide (NSC 697855) in vitro | Nitazoxanide (NSC 697855) cell line | Nitazoxanide (NSC 697855) concentration | Nitazoxanide (NSC 697855) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID